Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15?years follow-up

详细信息    查看全文

• 作者：Beatriz González-Yebra (1) (3)
  Raúl Peralta (1) (5)
  Ana Lilia González (2)
  Marco Antonio Ayala-Garcia (3)
  María E Medrano Ortiz de Zarate (4)
  Mauricio Salcedo (5)
  
• 关键词：Sporadic MTC ; M918T RET mutation ; Chromosomal alterations
• 刊名：Diagnostic Pathology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：7
• 期：1
• 全文大小：223KB
• 参考文献：1. Randolph GW, Maniar D: Medullary carcinoma of the thyroid. / Cancer Control 2000, 7:253-61.
  2. Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M, Busnardo B: Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. / Thyroid 1998, 8:517-23. CrossRef
  3. Ito Y, Miyauchi A, Yabuta T, Fukushima M, Inoue H, Tomoda C, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F: Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. / World J Surg 2009,33(1):58-6. CrossRef
  4. González B, Salcedo M, Medrano ME, Mantilla A, Qui?onez G, Benítez-Bibriesca L, Rodríguez-Cuevas S, Cabrera L, de León B, Altamirano N, Tapia J, Dawson B: RET oncogene mutations in medullary thyroid carcinoma in Mexican families. / Arch Med Res 2003,34(1):41-9. CrossRef
  5. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, H?ppener JW, van Amstel HK, Romeo G: A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. / Nature 1994, 367:375-76. CrossRef
  6. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A: Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. / Hum Mol Genet 1994, 3:237-41. CrossRef
  7. Zedenius J, Wallin G, Hamberger B, Nordenskj?ld M, Weber G, Larsson C: Somatic and MEN2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. / Hum Mol Genet 1994, 3:1259-262. CrossRef
  8. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Pfragner R, Behmel A, Lorenzo MJ: Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. / Genes Chromosomes Cancer 1995, 12:209-12. CrossRef
  9. Scurinni C, Quadro L, Fattoruso O, Verga U, Libroia A, Lupoli G, Cascone E, Marzano L, Paracchi S, Busnardo B, Girelli ME, Bellastella A, Colantuoni V: Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas. / Mol Cell Endocrinol 1998, 137:51-7. CrossRef
  10. Zedenius J, Larsson C, Bergholm U, Bovée J, Svensson A, Hallengren B, Grimelius L, B?ckdahl M, Weber G, Wallin G: Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. / J Clin Endocrinol Metabol 1995, 80:3088-090. CrossRef
  11. Schilling T, Bürk J, Sinn HP, Clemens A, Otto HF, H?ppner W, Herfarth C, Ziegler R, Schwab M, Raue F: Prognostic value of codon 918 (ATG?→?ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. / Int J Cancer 2001, 95:62-6. CrossRef
  12. Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F, Martino E, Romeo G, Pacini F: Somatic mutations of the RET protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. / J Clin Endocrinol Metabol 1996, 81:1619-622. CrossRef
  13. Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A: Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. / J Clin Endocrinol Metabol 2008, 93:682-87. CrossRef
  14. Pinkel D, Albertson DG: Comparative genomic hybridization. / Annu Rev Genomics Hum Genet 2005, 6:331-54. CrossRef
  15. Weiss MM, Hermsen MA, Meijer GA, van Grieken NC, Baak JP, Kuipers EJ, van Diest PJ: Comparative genomic hybridization. / Mol Pathol 1999, 52:243-51. CrossRef
  16. Frisk T, Zedenius J, Lundberg J, Wallin G, Kyt?l? S, Larsson C: CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome. / Int J Oncol 2001, 18:1219-225.
  17. Ye L, Santarpia L, Cote GJ, El-Naggar AK, Gagel RF: High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. / J Clin Endocrinol Metab 2008, 93:4367-372. CrossRef
  18. Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H: DNA copy number changes in thyroid carcinoma. / Am J Surg Pathol 1999, 154:1539-547.
  19. Marsh DJ, Theodosopoulos G, Martin-Schulte K, Richardson AL, Philips J, R?her HD, Delbridge L, Robinson BG: Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma. / J Clin Endocrinol Metab 2003, 88:1866-872. CrossRef
  20. Ameur N, Lacroix L, Roucan S, Roux V, Broutin S, Talbot M, Dupuy C, Caillou B, Schlumberger M, Bidart JM: Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways. / Endocr Relat Cancer 2009, 16:1261-272. CrossRef
  21. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS: A census of amplified and overexpressed human cancer genes. / Nat Rev Cancer 2010, 10:59-4. CrossRef
  22. Knuutila S, Bj?rkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y: DNA copy number amplification in human neoplasm. / Am J Pathol 1998, 152:1107-123.
  
• 作者单位：Beatriz González-Yebra (1) (3)
  Raúl Peralta (1) (5)
  Ana Lilia González (2)
  Marco Antonio Ayala-Garcia (3)
  María E Medrano Ortiz de Zarate (4)
  Mauricio Salcedo (5)
  
  1. Departamento de Medicina y Nutrición, División de Ciencias de la Salud, Campus León, Universidad de Guanajuato, Guanajuato, Mexico
  3. Hospital Regional de Alta Especialidad del Bajío, León, Guanajuato, México
  5. Laboratorio de Oncología Genómica, Unidad de Investigación Médica en Enfermedades Oncológicas, Hospital de Oncología, CMN SXXI-IMSS, Av. Cuauhtémoc 330, Col. Doctores, México, DF 06720, Mexico
  2. Departamento de Ciencias Aplicadas al Trabajo, División de Ciencias de la Salud, Campus León, Universidad de Guanajuato, Guanajuato, Mexico
  4. Departamento de Endocrinología, Hospital de Oncología, Centro Médico Nacional Siglo XXI-IMSS, México, DF, México
  

文摘

Background Association between DNA alterations and clinical parameters as recurrence, survival or prognosis has been found in a variety of tumors. A clear association between Medullary Thyroid Carcinoma (MTC) and RET oncogene mutation has been accepted. Specifically M918T RET mutation represents the main genetic event in most cases of sporadic MTC (SMTC) and limited chromosomal alterations analyses have been performed. Methods In the present work, a comparative genomic hybridization (CGH) study was performed using DNA from a primary tumor in a M918T RET mutation-positive SMTC patient and from its lymph node metastasis to investigate additional genetic alterations. We studied a patient with 15?years of follow-up and persistence of disease, confirmed by periodical elevated serum calcitonin (CT) levels. Results Only 3 chromosomal imbalances were identified in the primary tumor, gain of 18p, and loss of 6p and 16p region, whereas 25 chromosomal imbalances were identified in the metastasis (9 gains and 16 losses). Conclusion The chromosomal changes 6p-, 16p-, 18p-?could determine in part the oncogenic phenotype in the primary M918T RET positive tumor and probably related to persistence of high serum CT levels in this patient. The additional chromosomal changes observed could be related to the metastasis phenotype. We suggest that some genes mapped at 6p, 16p and 18p chromosomal regions, could act as genes associated to cancer and could be related to persistent SMTC and good prognosis. Virtual slides The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1720753793691097